Compare Gogoro Inc (GGR) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gogoro Inc vs Nuvalent Inc — how do they compare? Gogoro Inc trades at $3.8 (market cap $77.38M), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Nuvalent Inc is far larger — about 126.8× Gogoro Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Gogoro Inc nearer its low. Which is the better fit depends on your goals.
| GGR | NUVL | |
|---|---|---|
Market Cap | $77.38M | $9.81B |
Sector | Technology | Technology |
52-Week High | $7.89 | $123.96 |
52-Week Low | $2.74 | $72.16 |
Enterprise Value | $379.83M | $8.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gogoro Inc. (GGR) trades at $3.86, up 1.58% on the day, but remains in a technically bearish trend. Fundamentally, the company reported Q1 2026 results highlighting improved margins and positive operating cash flow, though it continues to post significant net losses with a -24.68% net income margin. The analyst consensus is unanimously neutral with a 100% Hold rating, reflecting caution despite recent operational progress.
The outlook is mixed. Opportunities stem from Gogoro's growing battery-swapping subscriber base and expansion into new markets like Vietnam. However, significant risks persist, including sustained unprofitability, high cash burn with a net cash flow of -$46.57M in 2025, and negative shareholder returns evidenced by a -50.38% ROE. The stock's low P/S of 0.21 suggests the market has heavily discounted its growth prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gogoro Inc
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
